US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (190)
  • Diseases & Conditions (3582)
  • Drug Delivery (174)
  • Therapeutic Area (5638)
  • Vaccines (590)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)
10/30/2014 | published by: Kalorama Information
... maternal-fetal medicine, as well as autoimmune disease and cystic fibrosis. At many clinics and practices focused on the health of women, a range of specialties are offered, which often results in a need for specific ...  |  read more...
USD 3,995
Adenosine A2A Receptor Antagonists -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... to establish the understanding for all the pipeline drugs that fall under Adenosine A2A Receptor Antagonists. This report provides information on the therapeutic development based on the Adenosine A2A Receptor Antagonists dealing with mechanism of ...  |  read more...
USD 1,250
Vacina Rotavirus Humano G1P1[8] (Atenuada)-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period ...  |  read more...
USD 1,000
Onitsit-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Croatia Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... from pharmacies andwholesalers over its pricing policies. We forecast weak pharmaceutical market growth over the nextdecade, in light of Croatia's acceding to EU pressure to rein in its budget deficit. With Croatia's economyremaining in the ...  |  read more...
USD 1,295
Gabon Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... has also been increased. Thiscontinued expansion, coupled with a high burden of disease, will drive the need for pharmaceuticalproducts providing opportunities for drugmakers. The continued presence of counterfeit drugs andinsufficient healthcare infrastructure are weaknesses of ...  |  read more...
USD 1,295
Kenya Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... models to market medicines in a country that has traditionally focussed on the treatment ofinfectious diseases such as malaria, tuberculosis and HIV. Besides challenges related to diagnosis, careand treatment, there is a lack of understanding ...  |  read more...
USD 1,295
Slovenia Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... is imminent over the coming monthsin the attempt to bring the budget deficit down. As a result, going into 2015 and 2016 we anticipate that thefocus will remain on local generic drugmakers, with limited opportunities ...  |  read more...
USD 1,295
Thailand Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... opportunities though risks stemming from cost containment policies and patent approvaldelays dampen the overall attractiveness. Headline Expenditure Projections Pharmaceuticals: THB142.5bn (USD4.64bn) in 2013 to THB146bn (USD4.49bn) in 2014; +2.49% inlocal currency terms and -3.12% in ...  |  read more...
USD 1,295
Antibodies in Oncology: Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 125 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 278 drug targets that are included ...  |  read more...
USD 6,746
Brain Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of brain cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 200 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Conjugated Drugs in Oncology: Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... specific intracellular signaling pathways for the treatment of more than 92 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 171 drug targets that are ...  |  read more...
USD 6,746
Head and Neck Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... 241 specific intracellular signaling pathways for the treatment of head and neck cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 158 drug targets that are included ...  |  read more...
USD 4,496
Hematological Cancers Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of hematological cancers. The rational for this plethora of treatment strategies is based on our increasing understanding of the 384 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Immunotherapy in Oncology: Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 153 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 400 drug targets that are included ...  |  read more...
USD 11,025
Lymphoma Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... signaling pathways for the treatment of lymphoma. The rational for this plethora of treatment strategies is based on our increasing understanding of the 235 drug targets that are included in this drug-pathway analyzing tool. No ...  |  read more...
USD 6,746
Melanoma Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... signaling pathways for the treatment of melanoma. The rational for this plethora of treatment strategies is based on our increasing understanding of the 244 drug targets that are included in this drug-pathway analyzing tool. No ...  |  read more...
USD 6,746
Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... than 223 specific intracellular signaling pathways for the treatment of more than 79 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 185 drug targets ...  |  read more...
USD 6,746
Ovarian Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of ovarian cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 248 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Pancreatic Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of pancreatic cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 280 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Peptides in Oncology: Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 82 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 193 drug targets that are included ...  |  read more...
USD 6,746
Prostate Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of prostate cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 272 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Protein Kinase Inhibitors Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... 250 specific intracellular signaling pathways for the treatment of more than 142 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 257 drug targets that ...  |  read more...
USD 8,996
OTC Medications in Brazil (2014) – Market Sizes
11/7/2014 | published by: Mintel - Snapshots
... products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Brazil is given in BRL with a minimum of ...  |  read more...
USD 600
Vitamins & Minerals in France (2014) – Market Sizes
11/18/2014 | published by: Mintel - Snapshots
... but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in France is given in EUR with a minimum of five years' historical ...  |  read more...
USD 600
< prev 1    3  4  5  6  7  8  9  10